Analystreport

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $12.00 price target on the stock.

FOAMIX PHARMACEUTICALS LTD  (FOMX) 
Last foamix pharmaceuticals ltd earnings: 11/11 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.foamix.co.il